Product Details for ANDA 202884
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE)
16MG;12.5MG
Marketing Status: Discontinued
32MG;12.5MG
Marketing Status: Discontinued
32MG;25MG
Marketing Status: Discontinued
16MG;12.5MG
Marketing Status: Discontinued
Active Ingredient: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 16MG;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202884
Product Number: 001
Approval Date: Dec 4, 2012
Applicant Holder Full Name: APOTEX INC
Marketing Status: Discontinued
Patent and Exclusivity Information
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE)
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 16MG;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202884
Product Number: 001
Approval Date: Dec 4, 2012
Applicant Holder Full Name: APOTEX INC
Marketing Status: Discontinued
Patent and Exclusivity Information
32MG;12.5MG
Marketing Status: Discontinued
Active Ingredient: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202884
Product Number: 002
Approval Date: Dec 4, 2012
Applicant Holder Full Name: APOTEX INC
Marketing Status: Discontinued
Patent and Exclusivity Information
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE)
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202884
Product Number: 002
Approval Date: Dec 4, 2012
Applicant Holder Full Name: APOTEX INC
Marketing Status: Discontinued
Patent and Exclusivity Information
32MG;25MG
Marketing Status: Discontinued
Active Ingredient: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202884
Product Number: 003
Approval Date: Jun 3, 2013
Applicant Holder Full Name: APOTEX INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202884
Product Number: 003
Approval Date: Jun 3, 2013
Applicant Holder Full Name: APOTEX INC
Marketing Status: Discontinued
Patent and Exclusivity Information